YiChang HEC ChangJiang Ph... (YIHCF)

PNK: YIHCF · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

YiChang HEC ChangJiang Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.67B	923.54M	1.13B	2.04B	2.78B	593.75M	887.18M	1.21B
Short-Term Investments	n/a	290M	n/a	n/a	n/a	n/a	346.52M	238.99M
Long-Term Investments	32.16M	5.16B	1.79B	4.41B	2.54B	1.76B	1.03B	402.5M
Other Long-Term Assets	1.45B	-5.3B	-65.32M	-4.45B	-2.64B	-1.8B	-1.06B	-495.68M
Receivables	2.09B	1.01B	479.04M	460.51M	2.2B	969.76M	721.91M	328.74M
Inventory	409.05M	315.03M	279.7M	378.27M	206.62M	196M	99.67M	116.16M
Other Current Assets	1.61B	2.48B	167.52M	380.37M	148.57M	25.86M	13.35M	5.51M
Total Current Assets	6.05B	5.01B	2.06B	3.26B	5.33B	1.79B	2.07B	1.9B
Property-Plant & Equipment	3.74B	3.52B	3.22B	2.84B	2.03B	1.35B	670.23M	495.68M
Goodwill & Intangibles	1.47B	1.78B	2.15B	1.61B	609.94M	445.03M	392.91M	81.77M
Total Long-Term Assets	6.69B	5.3B	7.15B	4.45B	2.64B	1.8B	1.06B	495.68M
Total Assets	12.74B	11.89B	10.54B	9.56B	9.91B	4.56B	3.78B	2.83B
Account Payables	200.52M	167.39M	115.32M	239.55M	184.69M	77.63M	55.37M	21.91M
Deferred Revenue	n/a	-3.13B	-48.48M	-2.82B	-132.66M	-53.4M	-10M	-70M
Short-Term Debt	2.32B	3.13B	48.48M	2.82B	132.66M	53.4M	10M	70M
Other Current Liabilities	414.33M	290.11M	515.77M	308.79M	475.76M	561.05M	445.72M	154.89M
Total Current Liabilities	4.33B	4.94B	1.24B	4.16B	2.31B	812.8M	640.75M	284.28M
Long-Term Debt	288.29M	691.53M	3.15B	189.85M	2.9B	n/a	10M	20M
Other Long-Term Liabilities	187.15M	n/a	n/a	106.54M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	476.6M	691.53M	3.15B	189.85M	2.9B	69.21M	10M	20M
Total Liabilities	4.81B	5.82B	4.52B	4.46B	5.29B	882.01M	715.39M	373.3M
Total Debt	2.61B	3.82B	3.19B	3.01B	3.04B	53.4M	20M	90M
Common Stock	879.97M	879.97M	879.97M	879.97M	448.82M	452.02M	452.02M	450.82M
Retained Earnings	4.39B	2.39B	2.32B	2.91B	2.73B	1.51B	879.24M	548.55M
Comprehensive Income	2.67B	2.61B	2.61B	1.11B	1.38B	1.48B	1.48B	1.46B
Shareholders Equity	7.94B	5.88B	5.81B	4.89B	4.41B	3.43B	2.81B	2.46B
Total Investments	32.16M	290M	1.79B	4.41B	2.54B	1.76B	346.52M	238.99M